Everything we've seen

1. !Jun 2, 7:01 AMsignal

   Agent 6 — Options Momentum — insufficient_capital

2. !Jun 1, 6:02 PMsignal

   Agent 6 — Options Momentum — insufficient_capital

3. !Jun 1, 7:01 AMsignal

   Agent 6 — Options Momentum — insufficient_capital

4. !May 29, 6:03 PMsignal

   Agent 6 — Options Momentum — insufficient_capital

5. !May 29, 7:01 AMsignal

   Agent 6 — Options Momentum — insufficient_capital

6. !May 28, 6:00 PMsignal

   Agent 6 — Options Momentum — insufficient_capital

7. ?May 20, 9:41 AMdecisionconsidered

   Agent 7 — Day Trader — decide: skip

   A is down ~2% with 364 minutes remaining (essentially the full session still ahead), so there is ample time for the move to extend. However, the setup is mixed. On the bearish side: the move is meaningful at -2%, suggesting real selling flow, and elevated 10-year inflation expectations (T10YIE at 2.5σ above trend) create a headwind for long-duration sensitive equities, which could include growth-oriented names. On the neutral/bullish side: there are no confirming headlines to anchor the narrative, which makes it harder to assign high conviction to continuation. The absence of a clear catalyst means this could be a technical or sector rotation move that fades as the day progresses. With no volume data available and no news to sustain momentum, this reads as an ordinary momentum setup without strong continuation pressure. Assigning 0.5 — borderline continuation, leaning into the trade given the system's asymmetric risk profile but not high conviction.

8. !May 20, 9:41 AMsignalseverity -0.02

   Agent 7 — Day Trader — day_trade_skipped

   A is down ~2% with 364 minutes remaining (essentially the full session still ahead), so there is ample time for the move to extend. However, the setup is mixed. On the bearish side: the move is meaningful at -2%, suggesting real selling flow, and elevated 10-year inflation expectations (T10YIE at 2.5σ above trend) create a headwind for long-duration sensitive equities, which could include growth-oriented names. On the neutral/bullish side: there are no confirming headlines to anchor the narrative, which makes it harder to assign high conviction to continuation. The absence of a clear catalyst means this could be a technical or sector rotation move that fades as the day progresses. With no volume data available and no news to sustain momentum, this reads as an ordinary momentum setup without strong continuation pressure. Assigning 0.5 — borderline continuation, leaning into the trade given the system's asymmetric risk profile but not high conviction.

9. ?May 20, 7:01 AMdecisionconsidered

   Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

   Agilent Technologies (A) is down 10.6% from its 30-day high with no clear fundamental catalyst visible in the evidence window — no negative news headlines, no adverse SEC filings, and no insider selling. The drop appears macro/sector-driven, as Health Care (XLV) is ranked 10th of 11 sectors by 30-day relative strength and is significantly underperforming SPY (-13.87pts over 30d), suggesting a broad sector headwind rather than company-specific impairment. However, the options flow shows a put/call ratio of 1.46 with elevated put volume, the sector flow proxy is deeply negative (-13.8M), and the broader market is under pressure today (SPY -1.20%, IWM -2.41%), all of which weigh against a near-term recovery.

10. !May 20, 7:01 AMsignalseverity 0.11

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    Agilent Technologies (A) is down 10.6% from its 30-day high with no clear fundamental catalyst visible in the evidence window — no negative news headlines, no adverse SEC filings, and no insider selling. The drop appears macro/sector-driven, as Health Care (XLV) is ranked 10th of 11 sectors by 30-day relative strength and is significantly underperforming SPY (-13.87pts over 30d), suggesting a broad sector headwind rather than company-specific impairment. However, the options flow shows a put/call ratio of 1.46 with elevated put volume, the sector flow proxy is deeply negative (-13.8M), and the broader market is under pressure today (SPY -1.20%, IWM -2.41%), all of which weigh against a near-term recovery.

11. ?May 20, 7:01 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash

    Wanted to buy but only $0.00 cash available; close=$110.57.

12. !May 20, 7:01 AMsignal

    Agent 5 — Dip Buyer (Evolving) — insufficient_capital

    Wanted to buy but only $0.00 cash available; close=$110.52.

13. ?May 19, 6:02 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash

    Wanted to buy but only $0.00 cash available; close=$110.52.

14. !May 19, 6:02 PMsignal

    Agent 5 — Dip Buyer (Evolving) — insufficient_capital

    Agilent Technologies (A) is down 11.5% from its 30-day high with no visible fundamental deterioration — no recent SEC filings, no guidance cuts, no insider selling, and no imminent earnings to create binary event risk. The options flow is modestly bullish (P/C ratio of 0.72, call volume exceeding put volume), and no hard veto conditions are triggered. The Health Care sector is underperforming the broader market on a 30-day basis (-10.79pts vs SPY), suggesting the drop is sector-wide rather than idiosyncratic to Agilent, which supports a mean-reversion thesis. Signal score is approximately +2 (sector underperformance +1, no earnings within 30 days +1, mild positive options flow +1, partially offset by elevated 10Y yield at 4.59% -1 and below-trend sector rank -0), landing at a marginal buy.

15. ?May 19, 6:02 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    Agilent Technologies (A) is down 10.6% from its 30-day high with no clear fundamental catalyst visible in the evidence window — no negative news headlines, no adverse SEC filings, and no insider selling. The drop appears macro/sector-driven, as Health Care (XLV) is ranked 10th of 11 sectors by 30-day relative strength and is significantly underperforming SPY (-13.87pts over 30d), suggesting a broad sector headwind rather than company-specific impairment. However, the options flow shows a put/call ratio of 1.46 with elevated put volume, the sector flow proxy is deeply negative (-13.8M), and the broader market is under pressure today (SPY -1.20%, IWM -2.41%), all of which weigh against a near-term recovery.

16. !May 19, 6:02 PMsignalseverity 0.12

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    Agilent Technologies (A) is down 10.6% from its 30-day high with no clear fundamental catalyst visible in the evidence window — no negative news headlines, no adverse SEC filings, and no insider selling. The drop appears macro/sector-driven, as Health Care (XLV) is ranked 10th of 11 sectors by 30-day relative strength and is significantly underperforming SPY (-13.87pts over 30d), suggesting a broad sector headwind rather than company-specific impairment. However, the options flow shows a put/call ratio of 1.46 with elevated put volume, the sector flow proxy is deeply negative (-13.8M), and the broader market is under pressure today (SPY -1.20%, IWM -2.41%), all of which weigh against a near-term recovery.

17. ?May 19, 6:01 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    There are no news headlines or recent SEC filings to indicate company-specific deterioration at Agilent Technologies (A), suggesting the ~10.2% pullback from its 30-day high is more likely attributable to macro or sector rotation pressures. However, the macro context shows 10-year inflation expectations (T10YIE) running 2.4σ above trend, which pressures long-duration, growth-sensitive equities like Agilent and could sustain valuation headwinds. With no positive catalyst visible in the evidence window and an elevated rate/inflation environment, the probability of a full rebound to prior highs within 90 days is modest.

18. !May 19, 6:01 PMsignalseverity 0.12

    Agent 4 — Dip Buyer (Frozen) — dip_skipped

    There are no news headlines or recent SEC filings to indicate company-specific deterioration at Agilent Technologies (A), suggesting the ~10.2% pullback from its 30-day high is more likely attributable to macro or sector rotation pressures. However, the macro context shows 10-year inflation expectations (T10YIE) running 2.4σ above trend, which pressures long-duration, growth-sensitive equities like Agilent and could sustain valuation headwinds. With no positive catalyst visible in the evidence window and an elevated rate/inflation environment, the probability of a full rebound to prior highs within 90 days is modest.

19. ?May 19, 9:28 AMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    There are no news headlines or recent SEC filings to indicate company-specific deterioration at Agilent Technologies (A), suggesting the ~10.2% pullback from its 30-day high is more likely attributable to macro or sector rotation pressures. However, the macro context shows 10-year inflation expectations (T10YIE) running 2.4σ above trend, which pressures long-duration, growth-sensitive equities like Agilent and could sustain valuation headwinds. With no positive catalyst visible in the evidence window and an elevated rate/inflation environment, the probability of a full rebound to prior highs within 90 days is modest.

20. ?May 19, 7:04 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — analyze: fail

    Analyze call failed: Anthropic call timed out after 25s — request aborted client-side

21. !May 19, 7:04 AMsignal

    Agent 5 — Dip Buyer (Evolving) — analyze_failed

22. ?May 19, 7:02 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    Agilent Technologies (A) is down 10.6% from its 30-day high with no clear fundamental catalyst visible in the evidence window — no negative news headlines, no adverse SEC filings, and no insider selling. The drop appears macro/sector-driven, as Health Care (XLV) is ranked 10th of 11 sectors by 30-day relative strength and is significantly underperforming SPY (-13.87pts over 30d), suggesting a broad sector headwind rather than company-specific impairment. However, the options flow shows a put/call ratio of 1.46 with elevated put volume, the sector flow proxy is deeply negative (-13.8M), and the broader market is under pressure today (SPY -1.20%, IWM -2.41%), all of which weigh against a near-term recovery.

23. !May 19, 7:02 AMsignalseverity 0.10

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    Agilent Technologies (A) is down 10.6% from its 30-day high with no clear fundamental catalyst visible in the evidence window — no negative news headlines, no adverse SEC filings, and no insider selling. The drop appears macro/sector-driven, as Health Care (XLV) is ranked 10th of 11 sectors by 30-day relative strength and is significantly underperforming SPY (-13.87pts over 30d), suggesting a broad sector headwind rather than company-specific impairment. However, the options flow shows a put/call ratio of 1.46 with elevated put volume, the sector flow proxy is deeply negative (-13.8M), and the broader market is under pressure today (SPY -1.20%, IWM -2.41%), all of which weigh against a near-term recovery.

24. ?May 18, 12:20 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    There are no news headlines or SEC filings in the window to suggest company-specific deterioration, meaning the ~10% drop from the 30-day high is likely attributable to macro or sector rotation pressures rather than fundamental damage. However, the macro context is notable: 5-year inflation breakevens (T5YIE) are running 2.5σ above trend, signaling elevated inflation expectations that tend to compress multiples for growth-oriented instruments and may weigh on Agilent Technologies (A), a precision instrumentation and life sciences company whose valuation is sensitive to rate/inflation dynamics. With no fresh catalysts visible and an inflationary macro headwind persisting, a full rebound to the 30-day high within 90 days is uncertain.

25. ?May 18, 9:25 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    Agilent Technologies (A) is down 10.6% from its 30-day high with no clear fundamental catalyst visible in the evidence window — no negative news headlines, no adverse SEC filings, and no insider selling. The drop appears macro/sector-driven, as Health Care (XLV) is ranked 10th of 11 sectors by 30-day relative strength and is significantly underperforming SPY (-13.87pts over 30d), suggesting a broad sector headwind rather than company-specific impairment. However, the options flow shows a put/call ratio of 1.46 with elevated put volume, the sector flow proxy is deeply negative (-13.8M), and the broader market is under pressure today (SPY -1.20%, IWM -2.41%), all of which weigh against a near-term recovery.

26. !May 18, 9:25 AMsignalseverity 0.11

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    Agilent Technologies (A) is down 10.6% from its 30-day high with no clear fundamental catalyst visible in the evidence window — no negative news headlines, no adverse SEC filings, and no insider selling. The drop appears macro/sector-driven, as Health Care (XLV) is ranked 10th of 11 sectors by 30-day relative strength and is significantly underperforming SPY (-13.87pts over 30d), suggesting a broad sector headwind rather than company-specific impairment. However, the options flow shows a put/call ratio of 1.46 with elevated put volume, the sector flow proxy is deeply negative (-13.8M), and the broader market is under pressure today (SPY -1.20%, IWM -2.41%), all of which weigh against a near-term recovery.

27. ?May 18, 9:00 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — analyze: fail

    Analyze call failed: No JSON object in analysis response: I'll work through the analytical framework systematically. **STEP 1 — HARD VETO CHECK:** - Earnings imminent: No upcoming earnings in visible window → No veto - Fundamental deterioration: No recent 1

28. !May 18, 9:00 AMsignal

    Agent 5 — Dip Buyer (Evolving) — analyze_failed

29. ?May 18, 8:54 AMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    There are no news headlines or SEC filings in the window to explain the 10.6% drop, suggesting the decline may be driven by macro rotation or broad market pressure rather than company-specific deterioration. However, the macro context shows 5-year inflation expectations running 2.5σ above trend, which creates headwinds for high-multiple instrumentation/life-science names like Agilent (ticker A), as rising real-rate fears compress growth valuations. With no fundamental catalyst confirmed either way, the risk/reward is ambiguous and confidence in a 90-day rebound to prior highs is moderate at best.

30. !May 18, 8:54 AMsignalseverity 0.11

    Agent 4 — Dip Buyer (Frozen) — dip_skipped

    There are no news headlines or SEC filings in the window to explain the 10.6% drop, suggesting the decline may be driven by macro rotation or broad market pressure rather than company-specific deterioration. However, the macro context shows 5-year inflation expectations running 2.5σ above trend, which creates headwinds for high-multiple instrumentation/life-science names like Agilent (ticker A), as rising real-rate fears compress growth valuations. With no fundamental catalyst confirmed either way, the risk/reward is ambiguous and confidence in a 90-day rebound to prior highs is moderate at best.

31. ?May 16, 6:35 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash

    Wanted to buy but only $6.08 cash available; close=$111.70.

32. ?May 16, 10:05 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    Ticker A (Agilent Technologies, Health Care sector) has dropped 10.6% from its 30-day high to $111.70, but the evidence base is almost entirely empty. There are no recent news headlines, no SEC filings, no insider activity, no options flow, and no upcoming earnings catalyst visible — making it impossible to distinguish whether this is an idiosyncratic dip or the beginning of a more sustained breakdown. The macro environment adds headwinds: today's broad market is broadly risk-off (SPY -1.20%, IWM -2.41%, small-caps leading lower), the 10Y yield at 4.47% is near the structural headwind threshold, and 5Y breakeven inflation (T5YIE) printing 2.7 — 2.5σ above trend — suggests inflation re-acceleration risk that is not favorable for growth-sensitive Health Care equipment/instrumentation names. VIX at the 50th percentile is neutral, not alarming, but the overall tone does not support aggressive dip-buying. Without any confirming signal — no insider cluster buying, no unusual call flow, no positive sector momentum, no fundamental catalyst — the dip cannot be attributed to a known, reversible cause. The absence of evidence is not evidence of safety; it simply means conviction cannot be established. Conservative underwriting requires declining this trade.

33. ?May 16, 9:19 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    Agilent Technologies (A) is down 10.6% from its 30-day high with virtually no actionable evidence to build a constructive thesis. There are no news headlines, no recent SEC filings, no insider buying activity, and no options flow data to suggest informed accumulation or a catalyst for recovery. The macro backdrop is mildly unfavorable: the 10Y yield at 4.47% is near the structural headwind threshold for a growth-sensitive life sciences/instrumentation name, and the 5-year inflation breakeven printing 2.7 (2.5σ above trend) introduces additional uncertainty around real rates and cost pressures. Broad market tone today is risk-off across the board (SPY -1.20%, IWM -2.41%), suggesting the dip may partly reflect macro selling rather than a company-specific mispricing. Health Care sector flow data is unavailable, making it impossible to determine whether A is underperforming its sector or simply moving with it. The absence of any positive confirming signals — no cluster insider buys, no unusual call flow, no identifiable catalyst — means this is a dip without a story, which fails the bar for a 90-day swing trade under a conservative framework.

34. ?May 16, 9:01 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    Agilent Technologies (A) shows no evidence of fundamental deterioration — no negative filings, no insider selling, and no adverse news headlines in the window — suggesting the 10.6% pullback from the 30-day high may be technically driven or macro-related rather than company-specific. However, the broad market is under meaningful pressure today (SPY -1.20%, IWM -2.41%, QQQ -1.51%) and inflation expectations are elevated (T5YIE at 2.5σ above trend), which weighs on growth-sensitive Health Care names like Agilent. With no confirming positive signals — no insider cluster buying, no unusual call flow, no sector outperformance data — there is insufficient evidence to confidently call a near-term rebound.

35. ?May 16, 9:00 AMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    There are no news headlines or SEC filings in the window to explain the 10.6% drop, suggesting the decline may be driven by macro rotation or broad market pressure rather than company-specific deterioration. However, the macro context shows 5-year inflation expectations running 2.5σ above trend, which creates headwinds for high-multiple instrumentation/life-science names like Agilent (ticker A), as rising real-rate fears compress growth valuations. With no fundamental catalyst confirmed either way, the risk/reward is ambiguous and confidence in a 90-day rebound to prior highs is moderate at best.

36. ?May 16, 8:58 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    Agilent Technologies (A) is a well-established life sciences and diagnostics instrumentation company with no recent negative filings, headlines, or insider selling to suggest fundamental deterioration — the drop appears market-driven rather than idiosyncratic. However, the broader macro and market context is unfavorable: indices are broadly lower today (SPY -1.20%, IWM -2.41%), inflation expectations are running 2.5σ above trend (T5YIE at 2.7), and the Health Care sector has no positive relative-strength data to provide a tailwind. With zero supporting signals — no insider buying cluster, no unusual options call flow, no bullish news catalyst — there is insufficient evidence to distinguish this dip as a recoverable pullback versus the beginning of a more sustained correction.

37. ?May 15, 6:37 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    Agilent Technologies (A) is a well-established life sciences and diagnostics instrumentation company with no recent negative filings, headlines, or insider selling to suggest fundamental deterioration — the drop appears market-driven rather than idiosyncratic. However, the broader macro and market context is unfavorable: indices are broadly lower today (SPY -1.20%, IWM -2.41%), inflation expectations are running 2.5σ above trend (T5YIE at 2.7), and the Health Care sector has no positive relative-strength data to provide a tailwind. With zero supporting signals — no insider buying cluster, no unusual options call flow, no bullish news catalyst — there is insufficient evidence to distinguish this dip as a recoverable pullback versus the beginning of a more sustained correction.

38. ?May 15, 6:33 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    Agilent Technologies (A) is a well-established life sciences and diagnostics instrumentation company with no recent negative filings, headlines, or insider selling to suggest fundamental deterioration — the drop appears market-driven rather than idiosyncratic. However, the broader macro and market context is unfavorable: indices are broadly lower today (SPY -1.20%, IWM -2.41%), inflation expectations are running 2.5σ above trend (T5YIE at 2.7), and the Health Care sector has no positive relative-strength data to provide a tailwind. With zero supporting signals — no insider buying cluster, no unusual options call flow, no bullish news catalyst — there is insufficient evidence to distinguish this dip as a recoverable pullback versus the beginning of a more sustained correction.

39. ?May 15, 6:24 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — analyze: fail

    Analyze call failed: Anthropic 400: {"type":"error","error":{"type":"invalid_request_error","message":"Your credit balance is too low to access the Anthropic API. Please go to Plans & Billing to upgrade or purchase credits."},"request_i

40. ?May 15, 6:23 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — analyze: fail

    Analyze call failed: Anthropic 400: {"type":"error","error":{"type":"invalid_request_error","message":"Your credit balance is too low to access the Anthropic API. Please go to Plans & Billing to upgrade or purchase credits."},"request_i

41. ?May 15, 6:15 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — analyze: fail

    Analyze call failed: Anthropic 400: {"type":"error","error":{"type":"invalid_request_error","message":"Your credit balance is too low to access the Anthropic API. Please go to Plans & Billing to upgrade or purchase credits."},"request_i

42. ?May 15, 3:38 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — analyze: fail

    Analyze call failed: Anthropic 400: {"type":"error","error":{"type":"invalid_request_error","message":"Your credit balance is too low to access the Anthropic API. Please go to Plans & Billing to upgrade or purchase credits."},"request_i

43. !May 15, 3:38 PMsignal

    Agent 8 — Dip Buyer (Peer-Aware) — analyze_failed